Sarah E. Nash - 10 Mar 2025 Form 4 Insider Report for Bath & Body Works, Inc. (BBWI)

Reporting relationship: Director
Issuer ticker: BBWI
Reported as of: 10 Mar 2025
Net transaction value: -$510,997
SEC form: 4
Accepted by SEC: 12 Mar 2025, 17:53:32 UTC
Prior SEC filing: 21 Nov 2024
Next SEC filing: 09 Jun 2025
Source filing: View source filing
Reporting owner signature: Robert J. Tannous, Attorney-in-Fact

Key filing fact

Sarah E. Nash filed Form 4 for Bath & Body Works, Inc. (BBWI) on 12 Mar 2025.

Key facts

This page summarizes Sarah E. Nash's Form 4 filing for Bath & Body Works, Inc. (BBWI).
3 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 12 Mar 2025, 17:53.

Change

Previous filing in this sequence was filed on 21 Nov 2024.
Current net transaction value: -$510,997.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

BBWI transaction

Common Stock, $0.50 par value

Options Exercise

Transaction value: $0
Shares: +127,288
Change %: +82%
Price: $0.000000
Shares after: 282,896
Date: 10 Mar 2025
Ownership: Direct

BBWI transaction

Common Stock, $0.50 par value

Tax liability

Transaction value: $510,997
Shares: -16,776
Change %: -5.9%
Price: $30.46
Shares after: 266,120
Date: 10 Mar 2025
Ownership: Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

BBWI transaction Derivative

Stock Unit

Options Exercise

Transaction value: $0
Shares: -127,288
Change %: -100%
Price: $0.000000
Shares after: 0
Date: 10 Mar 2025
Ownership: Direct
Underlying class: Common Stock, $0.50 par value
Underlying amount: 127,288
Exercise price
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

This award converts to common stock on a 1-for-1 basis.

Footnote F2

Final tranche vesting on March 10, 2025.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .